In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor

Patients with von Willebrand disease (VWD) often require treatment with supplemental von Willebrand factor (VWF) prior to procedures or to treat bleeding. Commercial VWF concentrates and more recently recombinant human VWF (rVWF) have replaced cryoprecipitate as the mainstay of therapy. In compariso...

Descripción completa

Detalles Bibliográficos
Autores principales: Colling, Meaghan E., Friedman, Kenneth D., Dzik, Walter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829641/
https://www.ncbi.nlm.nih.gov/pubmed/31496264
http://dx.doi.org/10.1177/1076029619873976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829641/
https://www.ncbi.nlm.nih.gov/pubmed/31496264
http://dx.doi.org/10.1177/1076029619873976

Ejemplares similares